It is important to differentiate between the femoral canal and the femoral triangle, particularly during exams when time is limited.

Understanding the Femoral Canal

The femoral canal is a fascial tunnel located at the medial aspect of the femoral sheath. It contains both the femoral artery and femoral vein, with the canal lying medial to the vein. The borders of the femoral canal include the femoral vein laterally, the lacunar ligament medially, the inguinal ligament anteriorly, and the pectineal ligament posteriorly.

The femoral canal plays a significant role in allowing the femoral vein to expand, which facilitates increased venous return to the lower limbs. However, it can also be a site of femoral hernias, which occur when abdominal contents protrude through the femoral canal. The relatively tight neck of the femoral canal places these hernias at high risk of strangulation, making it important to understand the anatomy and function of this structure. Overall, understanding the femoral canal is crucial for medical professionals in diagnosing and treating potential issues related to this area.

The rectum can produce potassium-rich secretions, which is why resins are given to treat hyperkalemia and why patients with villous adenoma of the rectum may experience hypokalemia.

Potassium Secretions in the GI Tract

Potassium is secreted in various parts of the gastrointestinal (GI) tract. The salivary glands can secrete up to 60mmol/L of potassium, while the stomach secretes only 10 mmol/L. The bile, pancreas, and small bowel also secrete potassium, with average figures of 5 mmol/L, 4-5 mmol/L, and 10 mmol/L, respectively. The rectum has the highest potassium secretion, with an average of 30 mmol/L. However, the exact composition of potassium secretions varies depending on factors such as disease, serum aldosterone levels, and serum pH.

It is important to note that gastric potassium secretions are low, and hypokalaemia (low potassium levels) may occur in vomiting. However, this is usually due to renal wasting of potassium rather than potassium loss in vomit. Understanding the different levels of potassium secretion in the GI tract can be helpful in diagnosing and treating potassium-related disorders.

Secretory diarrhoea is characterized by a change in the gut from an absorptive state to a secretory state, often caused by toxins or secretagogues. Chronic diarrhoea is usually caused by an underlying condition and can be classified into three subtypes: secretory, osmotic, and inflammatory. Secretory diarrhoea is characterized by large daily stool volumes and can occur even during fasting or sleep due to disrupted ion channels in the gastrointestinal tract. Osmotic diarrhoea is caused by something in the gut forcing water back into the lumen, often seen in malabsorption. Inflammatory diarrhoea is caused by inflammation of the bowel wall, either from medical disease or invasive organisms. Acute infectious diarrhoea can be invasive or enterotoxic/non-invasive, with the former presenting with bloody stool, leukocytosis, and fever, and the latter presenting with a watery stool and lacking systemic symptoms. In either case, WBCs can be detected in the stool.

Understanding Diarrhoea: Causes and Characteristics

Diarrhoea is defined as having more than three loose or watery stools per day. It can be classified as acute if it lasts for less than 14 days and chronic if it persists for more than 14 days. Gastroenteritis, diverticulitis, and antibiotic therapy are common causes of acute diarrhoea. On the other hand, irritable bowel syndrome, ulcerative colitis, Crohn’s disease, colorectal cancer, and coeliac disease are some of the conditions that can cause chronic diarrhoea.

Symptoms of gastroenteritis may include abdominal pain, nausea, and vomiting. Diverticulitis is characterized by left lower quadrant pain, diarrhoea, and fever. Antibiotic therapy, especially with broad-spectrum antibiotics, can also cause diarrhoea, including Clostridium difficile infection. Chronic diarrhoea may be caused by irritable bowel syndrome, which is characterized by abdominal pain, bloating, and changes in bowel habits. Ulcerative colitis may cause bloody diarrhoea, crampy abdominal pain, and weight loss. Crohn’s disease may cause crampy abdominal pain, diarrhoea, and malabsorption. Colorectal cancer may cause diarrhoea, rectal bleeding, anaemia, and weight loss. Coeliac disease may cause diarrhoea, abdominal distension, lethargy, and weight loss.

Other conditions associated with diarrhoea include thyrotoxicosis, laxative abuse, appendicitis, and radiation enteritis. It is important to seek medical attention if diarrhoea persists for more than a few days or is accompanied by other symptoms such as fever, severe abdominal pain, or blood in the stool.

The TNM classification system for colon cancer includes assessment of the primary tumor (T), regional lymph nodes (N), and distant metastasis (M). The T category ranges from TX (primary tumor cannot be assessed) to T4b (tumor directly invades or adheres to other organs or structures). The N category ranges from NX (regional lymph nodes cannot be assessed) to N2b (metastasis in 7 or more regional lymph nodes). The M category ranges from M0 (no distant metastasis) to M1b (metastases in more than 1 organ/site or the peritoneum).

Colorectal cancer referral guidelines were updated by NICE in 2015. Patients who are 40 years or older with unexplained weight loss and abdominal pain, those who are 50 years or older with unexplained rectal bleeding, and those who are 60 years or older with iron deficiency anaemia or a change in bowel habit should be referred urgently to colorectal services for investigation. Additionally, patients with positive results for occult blood in their faeces should also be referred urgently.

An urgent referral should be considered if there is a rectal or abdominal mass, an unexplained anal mass or anal ulceration, or if patients under 50 years old have rectal bleeding and any of the following unexplained symptoms or findings: abdominal pain, change in bowel habit, weight loss, or iron deficiency anaemia.

The NHS offers a national screening programme for colorectal cancer every two years to all men and women aged 60 to 74 years in England and 50 to 74 years in Scotland. Patients aged over 74 years may request screening. Eligible patients are sent Faecal Immunochemical Test (FIT) tests through the post. FIT is a type of faecal occult blood test that uses antibodies to detect and quantify the amount of human blood in a single stool sample. Patients with abnormal results are offered a colonoscopy.

The FIT test is also recommended for patients with new symptoms who do not meet the 2-week criteria listed above. For example, patients who are 50 years or older with unexplained abdominal pain or weight loss, those under 60 years old with changes in their bowel habit or iron deficiency anaemia, and those who are 60 years or older who have anaemia even in the absence of iron deficiency.

The myenteric plexus of the large intestine’s μ-opioid receptors are targeted by loperamide.

Antidiarrhoeal Agents: Opioid Agonists

Antidiarrhoeal agents are medications used to treat diarrhoea. Opioid agonists are a type of antidiarrhoeal agent that work by slowing down the movement of the intestines, which reduces the frequency and urgency of bowel movements. Two common opioid agonists used for this purpose are loperamide and diphenoxylate.

Loperamide is available over-the-counter and is often used to treat acute diarrhoea. It works by binding to opioid receptors in the intestines, which reduces the contractions of the muscles in the intestinal wall. This slows down the movement of food and waste through the intestines, allowing more time for water to be absorbed and resulting in firmer stools.

Diphenoxylate is a prescription medication that is often used to treat chronic diarrhoea. It works in a similar way to loperamide, but is often combined with atropine to discourage abuse and overdose.

Overall, opioid agonists are effective at treating diarrhoea, but should be used with caution and under the guidance of a healthcare professional. They can cause side effects such as constipation, dizziness, and nausea, and may interact with other medications.

Before prescribing any biologic medication, it is important to check the patient’s tuberculosis status by performing an interferon-gamma release assay. This test is used to detect TB latency and prevent reactivation of TB as a complication of biologic therapy. Other tests such as alpha-fetoprotein, spirometry, and brain-natriuretic peptide are not necessary before starting biologic treatment.

Biological Agents and Their Uses

Biological agents are substances that are used to target specific molecules or receptors in the body to treat various diseases. Adalimumab, infliximab, and etanercept are biological agents that inhibit TNF alpha, a molecule that plays a role in inflammation. These agents are used to treat Crohn’s disease and rheumatoid disease. Bevacizumab is an anti-VEGF agent that targets the growth of blood vessels in tumors. It is used to treat colorectal cancer, renal cancer, and glioblastoma. Trastuzumab is a biological agent that targets the HER receptor and is used to treat breast cancer. Imatinib is a tyrosine kinase inhibitor that is used to treat gastrointestinal stromal tumors and chronic myeloid leukemia. Basiliximab targets the IL2 binding site and is used in renal transplants. Cetuximab is an epidermal growth factor inhibitor that is used to treat EGF positive colorectal cancers. Biological agents have revolutionized the treatment of many diseases and continue to be an important area of research and development in medicine.

The small bowel receives a daily supply of bile ranging from 500 mL to 1.5 L, with the majority of bile salts being reused through the enterohepatic circulation. The contraction of the gallbladder results in a lumenal pressure of around 25 cm water, which can cause severe pain in cases of biliary colic.

Bile is a liquid that is produced in the liver at a rate of 500ml to 1500mL per day. It is made up of bile salts, bicarbonate, cholesterol, steroids, and water. The flow of bile is regulated by three factors: hepatic secretion, gallbladder contraction, and sphincter of oddi resistance. Bile salts are absorbed in the terminal ileum and are recycled up to six times a day, with over 90% of all bile salts being recycled.

There are two types of bile salts: primary and secondary. Primary bile salts include cholate and chenodeoxycholate, while secondary bile salts are formed by bacterial action on primary bile salts and include deoxycholate and lithocholate. Deoxycholate is reabsorbed, while lithocholate is insoluble and excreted.

Gallstones can form when there is an excess of cholesterol in the bile. Bile salts have a detergent action and form micelles, which have a lipid center that transports fats. However, excessive amounts of cholesterol cannot be transported in this way and will precipitate, resulting in the formation of cholesterol-rich gallstones.

Iron is absorbed from food in two forms: haem iron (found in meat) and non-haem iron (found in green vegetables). Haem iron is easier to absorb than non-haem iron. Non-haem iron is mostly in the form of insoluble ferric (Fe3+) iron, which needs to be converted to soluble ferrous (Fe2+) iron before it can be absorbed by the body. However, the amount of iron absorbed this way is often not enough to meet the body’s needs. Vegetarians and vegans are at higher risk of iron deficiency anaemia (IDA) because they consume less haem iron.

The patient’s symptoms suggest IDA caused by a change in diet, rather than anaemia of chronic disease. Ferritin is a marker of iron stores and is reduced in IDA. Hepcidin is a hormone that regulates iron storage in the body. Low serum hepcidin levels are seen in IDA, but this is not a reliable marker of the condition. Transferrin is a protein that binds to iron in the blood. In IDA, transferrin levels are high and ferritin levels are low. Transferrin saturation is low in IDA and anaemia of chronic disease, but high in haemochromatosis. Total iron-binding capacity (TIBC) is normal or high in IDA, but low in anaemia of chronic disease due to increased iron storage in cells and limited release into the blood.

Understanding Ferritin Levels in the Body

Ferritin is a protein found inside cells that binds to iron and stores it for later use. When ferritin levels are increased, it is usually defined as being above 300 µg/L in men and postmenopausal women, and above 200 µg/L in premenopausal women. However, it is important to note that ferritin is an acute phase protein, meaning that it can be synthesized in larger quantities during times of inflammation. This can lead to falsely elevated results, which must be interpreted in the context of the patient’s clinical picture and other blood test results.

There are two main categories of causes for increased ferritin levels: those without iron overload (which account for around 90% of patients) and those with iron overload (which account for around 10% of patients). Causes of increased ferritin levels without iron overload include inflammation, alcohol excess, liver disease, chronic kidney disease, and malignancy. Causes of increased ferritin levels with iron overload include primary iron overload (hereditary hemochromatosis) and secondary iron overload (which can occur after repeated transfusions).

On the other hand, reduced ferritin levels can be an indication of iron deficiency anemia. Since iron and ferritin are bound together, a decrease in ferritin levels can suggest a decrease in iron levels as well. Measuring serum ferritin levels can be helpful in determining whether a low hemoglobin level and microcytosis are truly caused by an iron deficiency state. It is important to note that the best test for determining iron overload is transferrin saturation, with normal values being less than 45% in females and less than 50% in males.

Peristalsis: The Movement of Food Through the Digestive System

Peristalsis is the process by which food is moved through the digestive system. Circular smooth muscle contracts behind the food bolus, while longitudinal smooth muscle propels the food through the oesophagus. Primary peristalsis spontaneously moves the food from the oesophagus into the stomach, taking about 9 seconds. Secondary peristalsis occurs when food does not enter the stomach, and stretch receptors are stimulated to cause peristalsis.

In the small intestine, peristalsis waves slow to a few seconds and cause a mixture of chyme. In the colon, three main types of peristaltic activity are recognised. Segmentation contractions are localised contractions in which the bolus is subjected to local forces to maximise mucosal absorption. Antiperistaltic contractions towards the ileum are localised reverse peristaltic waves to slow entry into the colon and maximise absorption. Mass movements are migratory peristaltic waves along the entire colon to empty the organ prior to the next ingestion of a food bolus.

Overall, peristalsis is a crucial process in the digestive system that ensures food is moved efficiently through the body.

The area known as the hepatobiliary triangle is defined by three borders: the common hepatic duct on the medial side, the cystic duct on the inferior side, and the inferior edge of the liver on the superior side. This space is particularly important during laparoscopic cholecystectomy, as it allows for safe ligation and division of the cystic duct and cystic artery. It’s worth noting that the common bile duct is formed by the joining of the common hepatic duct and the cystic duct, but it is not considered one of the borders of the hepatobiliary triangle. The cystic artery, on the other hand, is located within this anatomical space. Finally, while the gastroduodenal artery does arise from the common hepatic artery, it is not one of the borders of the hepatobiliary triangle.

The gallbladder is a sac made of fibromuscular tissue that can hold up to 50 ml of fluid. Its lining is made up of columnar epithelium. The gallbladder is located in close proximity to various organs, including the liver, transverse colon, and the first part of the duodenum. It is covered by peritoneum and is situated between the right lobe and quadrate lobe of the liver. The gallbladder receives its arterial supply from the cystic artery, which is a branch of the right hepatic artery. Its venous drainage is directly to the liver, and its lymphatic drainage is through Lund’s node. The gallbladder is innervated by both sympathetic and parasympathetic nerves. The common bile duct originates from the confluence of the cystic and common hepatic ducts and is located in the hepatobiliary triangle, which is bordered by the common hepatic duct, cystic duct, and the inferior edge of the liver. The cystic artery is also found within this triangle.

Chronic diarrhoea is defined by the WHO as lasting for more than 14 days. The leading causes of this condition are irritable bowel syndrome, ulcerative colitis and Crohn’s disease, coeliac disease, hyperthyroidism, and infection. The remaining options provided are incorrect and do not align with the WHO’s definition.

Understanding Diarrhoea: Causes and Characteristics

Diarrhoea is defined as having more than three loose or watery stools per day. It can be classified as acute if it lasts for less than 14 days and chronic if it persists for more than 14 days. Gastroenteritis, diverticulitis, and antibiotic therapy are common causes of acute diarrhoea. On the other hand, irritable bowel syndrome, ulcerative colitis, Crohn’s disease, colorectal cancer, and coeliac disease are some of the conditions that can cause chronic diarrhoea.

Symptoms of gastroenteritis may include abdominal pain, nausea, and vomiting. Diverticulitis is characterized by left lower quadrant pain, diarrhoea, and fever. Antibiotic therapy, especially with broad-spectrum antibiotics, can also cause diarrhoea, including Clostridium difficile infection. Chronic diarrhoea may be caused by irritable bowel syndrome, which is characterized by abdominal pain, bloating, and changes in bowel habits. Ulcerative colitis may cause bloody diarrhoea, crampy abdominal pain, and weight loss. Crohn’s disease may cause crampy abdominal pain, diarrhoea, and malabsorption. Colorectal cancer may cause diarrhoea, rectal bleeding, anaemia, and weight loss. Coeliac disease may cause diarrhoea, abdominal distension, lethargy, and weight loss.

Other conditions associated with diarrhoea include thyrotoxicosis, laxative abuse, appendicitis, and radiation enteritis. It is important to seek medical attention if diarrhoea persists for more than a few days or is accompanied by other symptoms such as fever, severe abdominal pain, or blood in the stool.

Barrett’s oesophagus is diagnosed in this patient based on the presence of metaplastic columnar epithelium in the oesophageal epithelium. The most significant risk factor for the development of Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD). While age is also a risk factor, it is not as strong as GORD. Alcohol consumption is not associated with Barrett’s oesophagus, but it is a risk factor for squamous cell oesophageal carcinoma. Infection with Helicobacter pylori is not linked to Barrett’s oesophagus, and it may even reduce the risk of GORD and Barrett’s oesophagus. Smoking is associated with both GORD and Barrett’s oesophagus, but the strength of this association is not as significant as that of GORD.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

Coeliac disease is characterized by villous atrophy, which leads to malabsorption. This patient’s symptoms are typical of coeliac disease, which can affect both males and females in their 50s. Patients often experience non-specific abdominal discomfort for several months, similar to irritable bowel syndrome, and may not notice correlations between symptoms and specific dietary components like gluten.

Aphthous ulceration is a common sign of coeliac disease, and patients may also experience nutritional deficiencies such as iron and folate deficiency due to malabsorption. Histology will reveal villous atrophy and crypt hyperplasia. Iron and folate deficiency can lead to a normocytic anaemia and conjunctival pallor. Positive anti-transglutaminase antibodies are specific for coeliac disease.

Ulcerative colitis is characterized by crypt abscess and mucosal ulcers, while Crohn’s disease is associated with non-caseating granulomas and full-thickness inflammation. These inflammatory bowel diseases typically present in patients in their 20s and may have systemic and extraintestinal features. Anti-tTG will not be positive in IBD. Ovarian cancer is an important differential diagnosis for females over 40 with symptoms similar to irritable bowel syndrome.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

Sutures do not hold well on the oesophagus due to the absence of a serosal covering. The Auerbach’s and Meissner’s nerve plexuses are situated between the longitudinal and circular muscle layers, as well as submucosally. The Meissner’s nerve plexus is located in the submucosa, which aids in its sensory function.

Anatomy of the Oesophagus

The oesophagus is a muscular tube that is approximately 25 cm long and starts at the C6 vertebrae, pierces the diaphragm at T10, and ends at T11. It is lined with non-keratinized stratified squamous epithelium and has constrictions at various distances from the incisors, including the cricoid cartilage at 15cm, the arch of the aorta at 22.5cm, the left principal bronchus at 27cm, and the diaphragmatic hiatus at 40cm.

The oesophagus is surrounded by various structures, including the trachea to T4, the recurrent laryngeal nerve, the left bronchus and left atrium, and the diaphragm anteriorly. Posteriorly, it is related to the thoracic duct to the left at T5, the hemiazygos to the left at T8, the descending aorta, and the first two intercostal branches of the aorta. The arterial, venous, and lymphatic drainage of the oesophagus varies depending on the location, with the upper third being supplied by the inferior thyroid artery and drained by the deep cervical lymphatics, the mid-third being supplied by aortic branches and drained by azygos branches and mediastinal lymphatics, and the lower third being supplied by the left gastric artery and drained by posterior mediastinal and coeliac veins and gastric lymphatics.

The nerve supply of the oesophagus also varies, with the upper half being supplied by the recurrent laryngeal nerve and the lower half being supplied by the oesophageal plexus of the vagus nerve. The muscularis externa of the oesophagus is composed of both smooth and striated muscle, with the composition varying depending on the location.

Familial adenomatous polyposis coli is characterized by the presence of multiple colonic adenomas, which are caused by mutations in the APC gene.

Polyposis syndromes are a group of genetic disorders that cause the development of multiple polyps in the colon and other parts of the gastrointestinal tract. These polyps can increase the risk of developing cancer, and therefore, early detection and management are crucial. There are several types of polyposis syndromes, each with its own genetic defect, features, and associated disorders.

Familial adenomatous polyposis (FAP) is caused by a mutation in the APC gene and is characterized by the development of over 100 colonic adenomas, with a 100% risk of cancer. Screening and management involve regular colonoscopies and resectional surgery if polyps are found. FAP is also associated with gastric and duodenal polyps and abdominal desmoid tumors.

MYH-associated polyposis is caused by a biallelic mutation of the MYH gene and is associated with multiple colonic polyps and an increased risk of right-sided cancers. Attenuated phenotype can be managed with regular colonoscopies, while resection and ileoanal pouch reconstruction are recommended for those with multiple polyps.

Peutz-Jeghers syndrome is caused by a mutation in the STK11 gene and is characterized by multiple benign intestinal hamartomas, episodic obstruction, and an increased risk of GI cancers. Screening involves annual examinations and pan-intestinal endoscopy every 2-3 years.

Cowden disease is caused by a mutation in the PTEN gene and is characterized by macrocephaly, multiple intestinal hamartomas, and an increased risk of cancer at any site. Targeted individualized screening is recommended, with extra surveillance for breast, thyroid, and uterine cancers.

HNPCC (Lynch syndrome) is caused by germline mutations of DNA mismatch repair genes and is associated with an increased risk of colorectal, endometrial, and gastric cancers. Colonoscopies every 1-2 years from age 25 and consideration of prophylactic surgery are recommended, along with extra colonic surveillance.

The pancreaticoduodenal artery supplies the pancreatic head, while branches of the splenic artery supply the pancreatic tail. There is an arterial watershed between the two regions.

Anatomy of the Pancreas

The pancreas is located behind the stomach and is a retroperitoneal organ. It can be accessed surgically by dividing the peritoneal reflection that connects the greater omentum to the transverse colon. The pancreatic head is situated in the curvature of the duodenum, while its tail is close to the hilum of the spleen. The pancreas has various relations with other organs, such as the inferior vena cava, common bile duct, renal veins, superior mesenteric vein and artery, crus of diaphragm, psoas muscle, adrenal gland, kidney, aorta, pylorus, gastroduodenal artery, and splenic hilum.

The arterial supply of the pancreas is through the pancreaticoduodenal artery for the head and the splenic artery for the rest of the organ. The venous drainage for the head is through the superior mesenteric vein, while the body and tail are drained by the splenic vein. The ampulla of Vater is an important landmark that marks the transition from foregut to midgut and is located halfway along the second part of the duodenum. Overall, understanding the anatomy of the pancreas is crucial for surgical procedures and diagnosing pancreatic diseases.

Using CEA as a screening tool for colonic cancer is not justifiable. While it is true that CEA levels are elevated in colonic cancer, this is also the case in non-malignant conditions such as cirrhosis and colitis. Additionally, the highest levels of CEA are typically seen in cases of metastatic disease. Therefore, CEA should not be used to monitor colitis patients for the development of colonic cancer. This information is supported by a study published in the BMJ in 2009.

Diagnosis and Staging of Colorectal Cancer

Diagnosis of colorectal cancer is typically done through a colonoscopy, which is considered the gold standard as long as it is complete and provides good mucosal visualization. Other options for diagnosis include double-contrast barium enema and CT colonography. Once a malignant diagnosis is made, patients will undergo staging using chest, abdomen, and pelvic CT scans. Patients with rectal cancer will also undergo evaluation of the mesorectum with pelvic MRI scanning. For examination purposes, the Dukes and TNM systems are preferred.

Tumour Markers in Colorectal Cancer

Carcinoembryonic antigen (CEA) is the main tumour marker in colorectal cancer. While not all tumours secrete CEA, it is still used as a marker for disease burden and is once again being used routinely in follow-up. However, it is important to note that CEA levels may also be raised in conditions such as IBD.

A tumor that secretes gastrin is known as a gastrinoma, which leads to an increase in both gastrointestinal motility and HCL production. It should be noted that while gastrin does increase gastric motility, it does not have an effect on the secretion of pancreatic fluid. This is instead regulated by hormones such as VIP, CCK, and secretin.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Coeliac disease leads to malabsorption as a result of villous atrophy in the distal duodenum. This case exhibits typical symptoms of coeliac disease, including iron deficiency anaemia, abdominal pain, and diarrhoea. The presence of a vesicular rash on the skin indicates dermatitis herpetiformis, a skin manifestation of coeliac disease. The patient’s Down syndrome also increases the risk of developing this condition. Macrophages invading the intestinal wall is an incorrect answer as lymphocytic infiltration is involved in the pathogenesis of coeliac disease. Pancreatic insufficiency is also an unlikely diagnosis as it typically causes malabsorption of fat-soluble vitamins and Vitamin B12, which is not evident in this case. Villous atrophy affecting the proximal colon is also incorrect as the small intestine is responsible for nutrient absorption in the body.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

The inferior rectal artery is a branch of the inferior mesenteric artery. It provides blood supply to the anal canal and the lower part of the rectum. It originates from the inferior mesenteric artery and runs downwards towards the anus, where it divides into several smaller branches.

The Inferior Mesenteric Artery: Supplying the Hindgut

The inferior mesenteric artery (IMA) is responsible for supplying the embryonic hindgut with blood. It originates just above the aortic bifurcation, at the level of L3, and passes across the front of the aorta before settling on its left side. At the point where the left common iliac artery is located, the IMA becomes the superior rectal artery.

The hindgut, which includes the distal third of the colon and the rectum above the pectinate line, is supplied by the IMA. The left colic artery is one of the branches that emerges from the IMA near its origin. Up to three sigmoid arteries may also exit the IMA to supply the sigmoid colon further down the line.

Overall, the IMA plays a crucial role in ensuring that the hindgut receives the blood supply it needs to function properly. Its branches help to ensure that the colon and rectum are well-nourished and able to carry out their important digestive functions.

Chronic pancreatitis can be attributed to genetic factors such as cystic fibrosis and hereditary haemochromatosis. In the case of a man with a slate-grey skin tone, it was discovered that he had developed cirrhosis due to untreated hereditary haemochromatosis. Despite being a hereditary condition, the man was never diagnosed earlier as he was an orphan and a recluse. Excessive alcohol consumption can also lead to cirrhosis and pancreatitis, but it would not explain the grey skin. Chronic hepatitis B infection is another cause of cirrhosis, but it would not be the reason for the pancreatitis.

Understanding Chronic Pancreatitis

Chronic pancreatitis is a condition characterized by inflammation that can affect both the exocrine and endocrine functions of the pancreas. While alcohol excess is the leading cause of this condition, up to 20% of cases are unexplained. Other causes include genetic factors such as cystic fibrosis and haemochromatosis, as well as ductal obstruction due to tumors, stones, and structural abnormalities.

Symptoms of chronic pancreatitis include pain that worsens 15 to 30 minutes after a meal, steatorrhoea, and diabetes mellitus. Abdominal x-rays and CT scans are used to detect pancreatic calcification, which is present in around 30% of cases. Functional tests such as faecal elastase may also be used to assess exocrine function if imaging is inconclusive.

Management of chronic pancreatitis involves pancreatic enzyme supplements, analgesia, and antioxidants. While there is limited evidence to support the use of antioxidants, one study suggests that they may be beneficial in early stages of the disease. Overall, understanding the causes and symptoms of chronic pancreatitis is crucial for effective management and treatment.

Chronic pancreatitis can cause diabetes as it destroys the islet of Langerhans cells in the pancreas. This patient has a history of recurrent admissions due to alcohol-related falls, indicating excessive alcohol intake, which is the most common risk factor for chronic pancreatitis. A high sugar diet alone should not consistently elevated blood sugar levels if normal insulin control mechanisms are functioning properly. Gastrointestinal bleeding and the stress response to injury would not immediately raise blood sugar levels. In this case, the patient’s alcohol intake suggests chronic pancreatitis as the cause of elevated blood sugar levels rather than type 2 diabetes mellitus.

Understanding Chronic Pancreatitis

Chronic pancreatitis is a condition characterized by inflammation that can affect both the exocrine and endocrine functions of the pancreas. While alcohol excess is the leading cause of this condition, up to 20% of cases are unexplained. Other causes include genetic factors such as cystic fibrosis and haemochromatosis, as well as ductal obstruction due to tumors, stones, and structural abnormalities.

Symptoms of chronic pancreatitis include pain that worsens 15 to 30 minutes after a meal, steatorrhoea, and diabetes mellitus. Abdominal x-rays and CT scans are used to detect pancreatic calcification, which is present in around 30% of cases. Functional tests such as faecal elastase may also be used to assess exocrine function if imaging is inconclusive.

Management of chronic pancreatitis involves pancreatic enzyme supplements, analgesia, and antioxidants. While there is limited evidence to support the use of antioxidants, one study suggests that they may be beneficial in early stages of the disease. Overall, understanding the causes and symptoms of chronic pancreatitis is crucial for effective management and treatment.

Ductal adenocarcinoma is the most frequently occurring type of pancreatic cancer, particularly in the head of the pancreas. Endocrine tumors of the pancreas are uncommon.

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. The majority of pancreatic tumors are adenocarcinomas and are typically found in the head of the pancreas. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and mutations in the BRCA2 and KRAS genes.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, and pruritus. Courvoisier’s law states that a palpable gallbladder is unlikely to be due to gallstones in the presence of painless obstructive jaundice. However, patients often present with non-specific symptoms such as anorexia, weight loss, and epigastric pain. Loss of exocrine and endocrine function can also occur, leading to steatorrhea and diabetes mellitus. Atypical back pain and migratory thrombophlebitis (Trousseau sign) are also common.

Ultrasound has a sensitivity of around 60-90% for detecting pancreatic cancer, but high-resolution CT scanning is the preferred diagnostic tool. The ‘double duct’ sign, which is the simultaneous dilatation of the common bile and pancreatic ducts, may be seen on imaging.

Less than 20% of patients with pancreatic cancer are suitable for surgery at the time of diagnosis. A Whipple’s resection (pancreaticoduodenectomy) may be performed for resectable lesions in the head of the pancreas, but side-effects such as dumping syndrome and peptic ulcer disease can occur. Adjuvant chemotherapy is typically given following surgery, and ERCP with stenting may be used for palliation.

The superficial perineal pouch is a compartment that is bordered superficially by the superficial perineal fascia, deep by the perineal membrane (which is the inferior fascia of the urogenital diaphragm), and laterally by the ischiopubic ramus. It contains various structures such as the crura of the penis or clitoris, muscles, viscera, blood vessels, nerves, the proximal part of the spongy urethra in males, and the greater vestibular glands in females. In cases of urethral rupture, the urine will tend to pass forward because the fascial condensations will prevent the urine from passing laterally and posteriorly.

The Urogenital Triangle and Superficial Perineal Pouch

The urogenital triangle is a structure formed by the ischiopubic inferior rami and ischial tuberosities, with a fascial sheet attached to its sides, creating the inferior fascia of the urogenital diaphragm. It serves as a pathway for the urethra in males and both the urethra and vagina in females. The membranous urethra is located deep to this structure and is surrounded by the external urethral sphincter.

In males, the superficial perineal pouch lies superficial to the urogenital diaphragm and contains the bulb of the penis, crura of the penis, superficial transverse perineal muscle, posterior scrotal arteries, and posterior scrotal nerves. Meanwhile, in females, the internal pudendal artery branches to become the posterior labial arteries in the superficial perineal pouch.

Understanding the anatomy of the urogenital triangle and superficial perineal pouch is crucial in diagnosing and treating urogenital disorders. Proper knowledge of these structures can aid in the identification of potential issues and the development of effective treatment plans.

The HLA most commonly associated with coeliac disease is HLA-DQ2. HLA, also known as human leukocyte antigen or major histocompatibility complex, is expressed on self-cells in the body and plays a role in presenting antigens to the immune system. The child’s symptoms of coeliac disease include fatty, floaty stools (steatorrhoea), weight loss, and positive tissue transglutaminase antibodies.

HLA-A01 is not commonly associated with autoimmune conditions, but has been linked to methotrexate-induced liver cirrhosis.

HLA-B27 is associated with psoriatic arthritis, reactive arthritis, ankylosing spondylitis, and inflammatory bowel disease.

HLA-B35 is not commonly associated with autoimmune conditions.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

A duodenal ulcer is unlikely to occur as a result of the decrease in gastric acid. However, it should be noted that gastric polyps may develop (refer to below).

Types of Gastritis and Their Features

Gastritis is a condition characterized by inflammation of the stomach lining. There are different types of gastritis, each with its own unique features. Type A gastritis is an autoimmune condition that results in the reduction of parietal cells and hypochlorhydria. This type of gastritis is associated with circulating antibodies to parietal cells and can lead to B12 malabsorption. Type B gastritis, on the other hand, is antral gastritis that is caused by infection with Helicobacter pylori. This type of gastritis can lead to peptic ulceration and intestinal metaplasia in the stomach, which requires surveillance endoscopy.

Reflux gastritis occurs when bile refluxes into the stomach, either post-surgical or due to the failure of pyloric function. This type of gastritis is characterized by chronic inflammation and foveolar hyperplasia. Erosive gastritis is caused by agents that disrupt the gastric mucosal barrier, such as NSAIDs and alcohol. Stress ulceration occurs as a result of mucosal ischemia during hypotension or hypovolemia. The stomach is the most sensitive organ in the GI tract to ischemia following hypovolemia, and prophylaxis with acid-lowering therapy and sucralfate may minimize complications. Finally, Menetrier’s disease is a pre-malignant condition characterized by gross hypertrophy of the gastric mucosal folds, excessive mucous production, and hypochlorhydria.

In summary, gastritis is a condition that can have different types and features. It is important to identify the type of gastritis to provide appropriate management and prevent complications.

The gastroduodenal artery originates from the upper portion of the duodenum and travels downwards behind it until it reaches the lower border. At this point, it splits into two branches: the right gastro-epiploic artery and the superior pancreaticoduodenal artery. The right gastro-epiploic artery moves towards the left and passes through the layers of the greater omentum to connect with the left gastro-epiploic artery.

The Gastroduodenal Artery: Supply and Path

The gastroduodenal artery is responsible for supplying blood to the pylorus, proximal part of the duodenum, and indirectly to the pancreatic head through the anterior and posterior superior pancreaticoduodenal arteries. It commonly arises from the common hepatic artery of the coeliac trunk and terminates by bifurcating into the right gastroepiploic artery and the superior pancreaticoduodenal artery.

To better understand the relationship of the gastroduodenal artery to the first part of the duodenum, the stomach is reflected superiorly in an image sourced from Wikipedia. This artery plays a crucial role in providing oxygenated blood to the digestive system, ensuring proper functioning and health.

Understanding the Femoral Canal

The femoral canal is a fascial tunnel located at the medial aspect of the femoral sheath. It contains both the femoral artery and femoral vein, with the canal lying medial to the vein. The borders of the femoral canal include the femoral vein laterally, the lacunar ligament medially, the inguinal ligament anteriorly, and the pectineal ligament posteriorly.

The femoral canal plays a significant role in allowing the femoral vein to expand, which facilitates increased venous return to the lower limbs. However, it can also be a site of femoral hernias, which occur when abdominal contents protrude through the femoral canal. The relatively tight neck of the femoral canal places these hernias at high risk of strangulation, making it important to understand the anatomy and function of this structure. Overall, understanding the femoral canal is crucial for medical professionals in diagnosing and treating potential issues related to this area.

Bilirubin is formed when haem, a component of red blood cells, is broken down by macrophages. Albumin, a binding protein in blood, can bind to bilirubin but does not contribute to its production. Jaundice in newborns is often caused by the breakdown of red blood cells. Urobilinogen is a byproduct of bilirubin metabolism that can be excreted through the urinary system. Glutamate, an amino acid and neurotransmitter, is not involved in bilirubin synthesis.

Understanding Bilirubin and Its Role in Jaundice

Bilirubin is a chemical by-product that is produced when red blood cells break down heme, a component found in these cells. This chemical is also found in other hepatic heme-containing proteins like myoglobin. The heme is processed within macrophages and oxidized to form biliverdin and iron. Biliverdin is then reduced to form unconjugated bilirubin, which is released into the bloodstream.

Unconjugated bilirubin is bound to albumin in the blood and then taken up by hepatocytes, where it is conjugated to make it water-soluble. From there, it is excreted into bile and enters the intestines to be broken down by intestinal bacteria. Bacterial proteases produce urobilinogen from bilirubin within the intestinal lumen, which is further processed by intestinal bacteria to form urobilin and stercobilin and excreted via the faeces. A small amount of bilirubin re-enters the portal circulation to be finally excreted via the kidneys in urine.

Jaundice occurs when bilirubin levels exceed 35 umol/l. Raised levels of unconjugated bilirubin may occur due to haemolysis, while hepatocyte defects, such as a compromised hepatocyte uptake of unconjugated bilirubin and/or defective conjugation, may occur in liver disease or deficiency of glucuronyl transferase. Raised levels of conjugated bilirubin can result from defective excretion of bilirubin, for example, Dubin-Johnson Syndrome, or cholestasis.

Cholestasis can result from a wide range of pathologies, which can be largely divided into physical causes, for example, gallstones, pancreatic and cholangiocarcinoma, or functional causes, for example, drug-induced, pregnancy-related and postoperative cholestasis. Understanding bilirubin and its role in jaundice is important in diagnosing and treating various liver and blood disorders.

Chronic pancreatitis can be diagnosed based on several factors, including alcohol abuse, elevated lipase levels, and normal amylase levels. An ERCP can confirm the diagnosis by revealing the characteristic chain of lakes appearance of the dilated and twisted main pancreatic duct. The absence of systemic symptoms makes a pancreatic abscess or necrosis unlikely, while a normal or absent pancreas is highly improbable.

Understanding Chronic Pancreatitis

Chronic pancreatitis is a condition characterized by inflammation that can affect both the exocrine and endocrine functions of the pancreas. While alcohol excess is the leading cause of this condition, up to 20% of cases are unexplained. Other causes include genetic factors such as cystic fibrosis and haemochromatosis, as well as ductal obstruction due to tumors, stones, and structural abnormalities.

Symptoms of chronic pancreatitis include pain that worsens 15 to 30 minutes after a meal, steatorrhoea, and diabetes mellitus. Abdominal x-rays and CT scans are used to detect pancreatic calcification, which is present in around 30% of cases. Functional tests such as faecal elastase may also be used to assess exocrine function if imaging is inconclusive.

Management of chronic pancreatitis involves pancreatic enzyme supplements, analgesia, and antioxidants. While there is limited evidence to support the use of antioxidants, one study suggests that they may be beneficial in early stages of the disease. Overall, understanding the causes and symptoms of chronic pancreatitis is crucial for effective management and treatment.